Материалов:
1 081 645

Репозиториев:
30

Авторов:
761 409

По вашему запросу найдено документов: 1081645

Страница 1 из 108165

Alterations of the respiratory system in heart failure
Begrambekova Yu L.
The use of diuretics in chronic heart failure. Position paper of the Russian Heart Failure Society [Экспертное мнение по применению диуретиков при хронической сердечной недостаточности Общество специалистов по сердечной недостаточности]
Mareev V.Yu., Garganeeva A.A., Ageev F.T., Arutunov G.P., Begrambekova Yu.L., Belenkov Yu.N., Vasyuk Yu.A., Galyavich A.S., Gilarevsky S.R., Glezer M.G., Drapkina O.M., Duplyakov D.V., Kobalava Zh.D., Koziolova N.A., Kuzheleva E.A., Mareev Yu.V., Ovchinnikov A.G., Orlova Ya.A., Perepech N.B., Sitnikova M.Yu., Skvortsov A.A., Skibitskiy V.V., Chesnikova A.I.
Position paper. The role of iron deficiency in patients with chronic heart failure and current corrective approaches
Mareev V.Yu., Gilyarevskiy S.R., Mareev Yu.V., Begrambekova Yu.L., Belenkov Yu.N., Vasyuk Yu.A., Galyavich A.S., Gendlin G.E., Glezer M.G., Kobalava Zh.D., Lelyavina T.A., Orlova Ya.A., Fomin I.V., Shaposhnik I.I.
Expert consensus regarding treatment of iron deficiency in stable and decompensated patients with heart failure
Mareev Y.V., Gilyarevskii S.R., Begrambekova Y.L., Lopatin Y.M., Garganeeva A.A., Duplyakov D.V., Kobalava Z.D., Golukhova E.Z., Koziolova N.A., Panov A.V., Lelyavina T.A., Drapkina O.M., Mareev V.Y.
[How evaluate results of treatment in patients with COVID-19? Symptomatic Hospital and Outpatient Clinical Scale for COVID-19 (SHOCS-COVID)].
Mareev V. Yu.
Russian heart failure society, Russian society of cardiology. Russian scientific medical society of internal medicine guidelines for heart failure: Chronic (CHF) and acute decompensated (ADHF). Diagnosis, prevention and treatment
Mareev V. Yu
Proactive anti-inflammatory therapy with colchicine in the treatment of advanced stages of new coronavirus infection. The first results of the COLORIT study
Mareev V. Yu
Hydroxychloroquine in patients with novel coronavirus infection (COVID-19): a case-control study.
Kamalov A. A.
to stages I-II, the CRP level should not exceed 60 mg/dL, and oxygen saturation in the air within 92-98%. We
[Combination therapy at an early stage of the novel coronavirus infection (COVID-19). Case series and design of the clinical trial "BromhexIne and Spironolactone for CoronаvirUs Infection requiring hospiTalization (BISCUIT)"].
Mareev V. Yu.
[Proactive anti-inflammatory and anticoagulant therapy in the treatment of advanced stages of novel coronavirus infection (COVID-19). Case Series and Study Design: COLchicine versus ruxolitinib and secukinumab in open prospective randomIzed trial (COLORIT)].
Mareev V. Yu.

Страница 1 из 108165

Фасеты

Партнеры

КФУ
ТГУ
Elpub
СФУ
Webpublishers

Индексация

BASE
WorldCat
OpenAIRE
EDS
core